Clinical Trial Update: Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism [Phase 3]

View source ↗

Summary

Phase III trial evaluating morning testosterone normalization in men with secondary hypogonadism has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Secondary Hypogonadism | Phase 3 | Status: COMPLETED | Results posted: 2015-05-27